Director/PDMR Shareholding

RNS Number : 3344I
GlaxoSmithKline PLC
01 July 2013
 



 

Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

 

 

The Administrators of the GlaxoSmithKline 2009 Deferred Annual Bonus Plan (the Plan) notified the Company and the under-mentioned persons on 28 June 2013 of an increase in their notional interests in Ordinary Shares and American Depositary Shares (ADSs) at a price of 1549.50 pence per Ordinary Share and $47.75 per ADS following the notional re-investment of the dividend paid to shareholders on 11 April 2013.

 

 

Sir Andrew Witty

Acquisition of 441 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 441 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr S Dingemans

Acquisition of 167 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 167 Ordinary Shares under the matching element of the Plan (Company contribution).



Dr M M Slaoui

 

Acquisition of 228 ADSs under the personal contribution element of the Plan.




Acquisition of 228 ADSs under the matching element of the Plan (Company contribution).



Mr R G Connor

Acquisition of 69 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 69 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr W C Louv

Acquisition of 46 ADSs under the personal contribution element of the Plan.




Acquisition of 46 ADSs under the matching element of the Plan (Company contribution).



Mr D S Redfern

Acquisition of 93 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 93 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr P C Thomson

Acquisition of 13 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 13 Ordinary Shares under the matching element of the Plan (Company contribution).

Mr D E Troy

Acquisition of 86 ADSs under the personal contribution element of the Plan.




Acquisition of 86 ADSs under the matching element of the Plan (Company contribution).



Dr P J T Vallance

Acquisition of 294 Ordinary Shares under the personal contribution element of the Plan.

 


Acquisition of 294 Ordinary Shares under the matching element of the Plan (Company contribution).



Ms E Walmsley

Acquisition of 179 Ordinary Shares under the personal contribution element of the Plan.

 


Acquisition of 179 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

The notional dividends accrued will be paid out in proportion to the percentage of the participant's deferred annual bonus holdings that will vest following the end of the relevant three year measurement period.

 

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

V A Whyte

Company Secretary

 

1 July 2013

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEFLFBXDFZBBK

Companies

GSK (GSK)
UK 100